Pharmaceutical Technology

JULY 25, 2022

With decreasing margins on the horizon, pharma manufacturers have long shown an interest in specialty generics, which is only expected to rise in the future. Despite this, specialty generics are expected to be the domain of a handful of companies with the necessary manufacturing capabilities and legal backing needed for entering the market.

Drugs 298

Drugs Manufacturing Production Marketing 298

Drug Patent Watch

DECEMBER 10, 2024

The Importance of Scientific Expertise Generic drug development involves a deep understanding of the scientific principles underlying drug development, including pharmacology, pharmacokinetics, and bioequivalence. Bioequivalence Studies : Bioequivalence studies are a critical component of generic drug development. Johnson, W.

Generic Drugs 98

Generic Drugs Bioequivalency Development Drugs 98

Pharmacy Checkers

FEBRUARY 14, 2020

Joe and Teresa Graedon, founders of The People’s Pharmacy , not only have an admirable track record of telling health consumers how it is, but also listening to those in their readership. Sure enough, ConsumerLab.com discovered that the 300mg version was clearly not bioequivalent. pharmacies is manufactured and sold in Canada as well.

Branding 62

Branding FDA Approval Pharmacy Bioequivalency 62

Druggist

MARCH 25, 2021

Can I ask the pharmacy to dispense Cerazette instead of Cerelle? Although the active ingredient is the same, there are differences in non-active components (the core of the tablet and coating), which reflect both pills’ manufacturing process. Can I ask the pharmacy to dispense Cerazette instead of Cerelle? .

Branding 98

Branding Bioequivalency Pharmacy Generic Drugs 98

XTalks

FEBRUARY 8, 2021

As a subset of biosimilars, interchangeable biological products can be substituted for the reference product at the pharmacy level, without the input of the prescribing physician. Unlike small-molecule generic drugs, biosimilars do not need to demonstrate bioequivalence to the innovator product.

Production 78

Production Insulin Branding Generic Drugs 78

World of DTC Marketing

FEBRUARY 21, 2022

Pfizer and Merck have chosen to designate a select few generic manufacturers to produce cheaper versions of their drugs through the Medicines Patent Pool (MPP). Reportedly, the cost of production for molnupiravir stands at about $17.74. Experts across the board are predicting demand for antiviral drugs will rapidly outpace supply.

Regulation 218

Regulation Drugs Bioequivalency Vaccination 218